The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
Open accessPublished version of a preprint
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Tumor adaptation or selection is thought to underlie therapy resistance in glioma. To investigate longitudinal epigenetic evolution of gliomas in response to therapeutic pressure, we performed an epigenomic analysis of 132 matched initial and recurrent tumors from patients with IDH-wildtype (IDHwt) and IDH-mutant (IDHmut) glioma. IDHwt gliomas showed a stable epigenome over time with relatively low levels of global methylation. The epigenome of IDHmut gliomas showed initial high levels of genome-wide DNA methylation that was progressively reduced to levels similar to those of IDHwt tumors. Integration of epigenomics, gene expression, and functional genomics identified HOXD13 as a master regulator of IDHmut astrocytoma evolution. Furthermore, relapse of IDHmut tumors was accompanied by histologic progression that was associated with survival, as validated in an independent cohort. Finally, the initial cell composition of the tumor microenvironment varied between IDHwt and IDHmut tumors and changed differentially following treatment, suggesting increased neoangiogenesis and T-cell infiltration upon treatment of IDHmut gliomas. This study provides one of the largest cohorts of paired longitudinal glioma samples with epigenomic, transcriptomic, and genomic profiling and suggests that treatment of IDHmut glioma is associated with epigenomic evolution toward an IDHwt-like phenotype. Significance: Standard treatments are related to loss of DNA methylation in IDHmut glioma, resulting in epigenetic activation of genes associated with tumor progression and alterations in the microenvironment that resemble treatment-naïve IDHwt glioma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the grading criteria in the current classification schema for oligodendrogliomas continues to predominantly rely upon histopathologic examination; the differentiating criterion between grade 2 and grade 3 oligodendrogliomas are the presence of conspicuous microvascular proliferation and/or 6 mitoses per 10 high-power field [3,4,5,6,7,8,9,10,11].”
From BPC 157 Therapy of Myotendinous Junction Injury in Rats (2025) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tang, B., Qi, G., Sun, X., Tang, F., Yuan, S., Wang, Z., Liang, X., Li, B., Yu, S., Liu, J., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0540-4 · Cited by 41 · cited 1×
“The MethylCIBERSORT R package was used to derive the DNA methylation signature for the deconvolution and the signature matrix was exported and uploaded to the CIBERSORTx portal to be deconvoluted using 1,000 permutations without quantile normalization.”
RetractedThe Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Self-citationThe 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273 · cited 1×
“Allimageswereanalyzedin a blinded fashion.”
Self-citationBioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 3×
“Blood.450k Bioconductor package version 1.30.0 (44).”
InfluentialMultiQC: summarize analysis results for multiple tools and samples in a single report
Ewels, P., Magnusson, M., Lundin, S., & Käller, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw354 · Cited by 10,143
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231 · cited 1×
“Next, batch effects due to the different Aliquot Batches were corrected using the COMBAT algorithm with aliquots as covariates (25).”
MethodDetermining cell type abundance and expression from bulk tissues with digital cytometry
Newman, A. M., Steen, C. B., Liu, C. L., Gentles, A. J., Chaudhuri, A. A., Scherer, F., Khodadoust, M. S., Esfahani, M. S., Luca, B. A., Steiner, D., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0114-2 · Cited by 4,478
Aryee, M. J., Jaffe, A. E., Corrada-Bravo, H., Ladd-Acosta, C., Feinberg, A. P., Hansen, K. D., & Irizarry, R. A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu049 · Cited by 4,397
Cited by
van den Bent, M. J., French, P. J., Brat, D., Tonn, J. C., Touat, M., Ellingson, B. M., Young, R. J., Pallud, J., von Deimling, A., Sahm, F., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae107 · Cited by 88
“132,133 In parallel to these findings, a German group developed a classifier to aid the typing of brain tumors.”
BackgroundSelf-citationSystemic and local immunosuppression in glioblastoma and its prognostic significance
Stepanenko, A. A., Sosnovtseva, A. O., Valikhov, M. P., Chernysheva, A. A., Abramova, O. V., Ka, P., & Chekhonin, V. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1326753 · Cited by 50
Lucas, C. G., Al-Adli, N. N., Young, J. S., Gupta, R. K., Morshed, R. A., Wu, J., Ravindranathan, A., Shai, A., Bush, N. A. O., Taylor, J. W., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae214 · Cited by 43
Self-citationMotevasseli, M., Darvishi, M., Khoshnevisan, A., Zeinalizadeh, M., Saffar, H., Bayat, S., Najafi, A., Abbaspour, M. J., Mamivand, A., Olson, S. B., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01837-5 · Cited by 34
“This demethylation event could lead to the epigenetic activation of genes associated with tumor progression, creating a TME resembling treatment-naive IDH-WT gliomas [92].”
BackgroundLu, J., Huo, W., Ma, Y., Wang, X., & Yu, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217185 · Cited by 29
Metadata
- Authors
- Malta, T. M., Sabedot, T. S., Morosini, N. S., Datta, I., Garofano, L., Vallentgoed, W., Varn, F. S., Aldape, K., D'Angelo, F., Bakas, S., Barnholtz-Sloan, J. S., Gan, H. K., Hasanain, M., Hau, A.-C., Johnson, K. C., Cazacu, S., deCarvalho, A. C., Khasraw, M., Kocakavuk, E., Kouwenhoven, M. C. M., Migliozzi, S., Niclou, S. P., Niers, J. M., Ormond, D. R., Paek, S. H., Reifenberger, G., Sillevis Smitt, P. A., Smits, M., Stead, L. F., van den Bent, M. J., Van Meir, E. G., Walenkamp, A., Weiss, T., Weller, M., Westerman, B. A., Ylstra, B., Wesseling, P., Lasorella, A., French, P. J., Poisson, L. M., Consortium The GLASS, Woehrer, A., Lowman, A. K., deCarvalho, A. C., Castro, A. V., Transou, A., Brodbelt, A. R., Hau, A.-C., Lasorella, A., Golebiewska, A., Walenkamp, A., Molinaro, A. M., Iavarone, A., Ismail, A., Westerman, B. A., Ylstra, B., Bock, C., Ormond, D. R., Brat, D. J., Kocakavuk, E., Van Meir, E. G., Barthel, F. P., Varn, F. S., D'Angelo, F., Finocchiaro, G., Rao, G., Zadeh, G., Reifenberger, G., ngNg, H. K., Kim, H., Noushmehr, H., Miletic, H., Gan, H. K., Datta, I., Rock, J., Snyder, J. M., Huse, J. T., Connelly, J. M., Barnholtz-Sloan, J. S., Niers, J. M., deGroot, J. F., Akdemir, K. C., Kannan, K. S., Ligon, K. L., Aldape, K., Bulsara, K. R., Johnson, K. C., Alfaro, K. D., Poisson, L. M., Garofano, L., Stead, L. F., Nasrallah, M. P., Smits, M., van den Bent, M. J., Kouwenhoven, M. C., Weller, M., Hasanain, M., Khasraw, M., Gould, P. V., Smitt, P. A. S., LaViolette, P. S., Tatman, P. D., Wesseling, P., French, P. J., Beroukhim, R., Verhaak, R. G. W., Migliozzi, S., Niclou, S. P., Bakas, S., Kalkanis, S., Paek, S. H., Short, S. C., Ghazaleh, T., Malta, T. M., Sabedot, T. S., Weiss, T., Walbert, T., Baid, U., Vallentgoed, W., Yung, W. K. A., Verhaak, R. G. W., Iavarone, A., & Noushmehr, H.
- Affiliations
- Henry Ford Health (US)
- 16Department of Neurology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Yale University (US)
- ORCID
- Venue
- Cancer Research
- Published
- 2023-12-20
- Volume
- 84
- Issue
- 5
- Pages
- 741-756
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC10911804
- OpenAlex
- W4389992531
- Cited by
- 68
- References
- 97
- Citations by year
- 2026: 23 · 2025: 24 · 2024: 19
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cancer Research (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by-nc-nd)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-nd)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/00583-0, 2019/14928-1)
- National Institutes of Health (R01CA222146, R21 NS114873, Cancer Center Support Grant P30 CA034196, R01CA270365, R01NS096236, R01NS117666, R01NS042645, P50CA190991-07)
- Fonds National de la Recherche Luxembourg (CORE C20/BM/14646004, FNRS-Televie TETHER)
- Jackson Laboratory (JAX Scholar Program and a postdoctoral fellowship from The Jane Coffin Childs Memorial Fund for Medi)
- U.S. Department of Defense (CA170278)
- Anschutz Medical Campus, University of Colorado
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- glioma, IDH mutation, epigenetic evolution, DNA methylation, treatment resistance, recurrent glioma, HOXD13, astrocytoma, tumor microenvironment, neoangiogenesis, T cell infiltration, tumor recurrence, histological progression, epigenetic reprogramming
- MeSH terms
- Brain Neoplasms, Glioma, Humans, Isocitrate Dehydrogenase, Mutation, Neoplasm Recurrence, Local, Epigenesis, Genetic, Epigenomics, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen. https://app.cochat.ai/papers/10.1158/0008-5472.can-23-2093
- The paper
- Malta, T. M., Sabedot, T. S., Morosini, N. S., Datta, I., Garofano, L., Vallentgoed, W., Varn, F. S., Aldape, K., D'Angelo, F., Bakas, S., Barnholtz-Sloan, J. S., Gan, H. K., Hasanain, M., Hau, A.-C., Johnson, K. C., Cazacu, S., deCarvalho, A. C., Khasraw, M., Kocakavuk, E., . . . Noushmehr, H. (2024). The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen. Cancer Research. https://doi.org/10.1158/0008-5472.can-23-2093
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.